nodes	percent_of_prediction	percent_of_DWPC	metapath
Buclizine—Fluspirilene—DRD2—Gilles de la Tourette syndrome	0.0494	0.414	CrCbGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0489	0.0555	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0487	0.0553	CbGpPWpGaD
Buclizine—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0417	0.0473	CbGpPWpGaD
Buclizine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0416	0.0472	CbGpPWpGaD
Buclizine—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0405	0.046	CbGpPWpGaD
Buclizine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0404	0.0458	CbGpPWpGaD
Buclizine—Fluspirilene—HTR2A—Gilles de la Tourette syndrome	0.0381	0.32	CrCbGaD
Buclizine—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0377	0.0428	CbGpPWpGaD
Buclizine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0376	0.0427	CbGpPWpGaD
Buclizine—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0351	0.0398	CbGpPWpGaD
Buclizine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0349	0.0397	CbGpPWpGaD
Buclizine—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.034	0.0386	CbGpPWpGaD
Buclizine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0339	0.0385	CbGpPWpGaD
Buclizine—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0317	0.036	CbGpPWpGaD
Buclizine—Cinnarizine—DRD2—Gilles de la Tourette syndrome	0.0316	0.266	CrCbGaD
Buclizine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0316	0.0359	CbGpPWpGaD
Buclizine—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0264	0.03	CbGpPWpGaD
Buclizine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0263	0.0299	CbGpPWpGaD
Buclizine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0222	0.0252	CbGpPWpGaD
Buclizine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0221	0.0251	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.0098	0.0111	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00951	0.0108	CbGpPWpGaD
Buclizine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00886	0.0101	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00805	0.00914	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00802	0.00911	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00781	0.00887	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00779	0.00884	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00728	0.00826	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00726	0.00824	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0069	0.00783	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00687	0.0078	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00669	0.0076	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00667	0.00758	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00659	0.00749	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00657	0.00746	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00624	0.00708	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00622	0.00706	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.0059	0.0067	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00588	0.00667	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00525	0.00596	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00523	0.00594	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0051	0.00579	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0051	0.00579	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00508	0.00577	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00508	0.00577	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00475	0.00539	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00473	0.00537	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00437	0.00496	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00435	0.00494	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00333	0.00378	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00332	0.00376	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00297	0.00337	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00296	0.00336	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00288	0.00327	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00287	0.00326	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00269	0.00306	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00269	0.00305	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00268	0.00305	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00268	0.00304	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00262	0.00297	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00261	0.00296	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00244	0.00277	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00243	0.00276	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00188	0.00213	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00187	0.00213	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00171	0.00194	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0017	0.00193	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00159	0.00181	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00159	0.0018	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00155	0.00175	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00154	0.00175	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00144	0.00163	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00144	0.00163	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00114	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00101	0.00114	CbGpPWpGaD
